Current interventions for the treatment of acute kidney injury (AKI) are not satisfactory, and it
is time to approach new strategies in order to definitely take a step forward. At its beginning …

In search for new sources of mesenchymal stem cells (MSCs) for renal repair in acute kidney
injury (AKI), we investigated the potential of human cord blood (CB)-MSCs to cure mice with …

Transplantation of bone marrow mesenchymal stem cells (BM-MSC) or stromal cells from
rodents has been identified as a strategy for renal repair in experimental models of acute …

Background Clinically, acute kidney injury (AKI) is a potentially devastating condition for
which no specific therapy improves efficacy of the repair process. Bone marrow …

Mesenchymal stem cells (MSCs) and their conditioned medium (CM) have been shown to
ameliorate acute kidney injury (AKI). Potential risks of using stem cells are their participation …

Mesenchymal stem cells are currently considered as a promising tool for therapeutic
application in acute kidney injury (AKI) management. AKI is characterized by acute tubular …

Acute kidney injury (AKI) is a common syndrome with a high mortality and morbidity rate.
Recent developments in stem cell research have shown great promise for the treatment of …

The most commonly used therapeutic targets in nephrology are the reduction of injury, the
delay of progression, or renal replacement therapy. Many animal and human studies …

Background: Acute kidney injury (AKI) is a multifaced disease characterized by a rapid
decline in renal function. However, with growing insight into the pathophysiologic …

Every year 13.3 million people suffer acute kidney injury (AKI), which is associated with a
high risk of death or development of long-term chronic kidney disease (CKD) in a substantial …